We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

56 hedge funds and large institutions have $21.2M invested in Actinium Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 8

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

78% more capital invested

Capital invested by funds: $11.9M → $21.2M (+$9.31M)

55% more call options, than puts

Call options by funds: $3.44M | Put options by funds: $2.23M

12% more funds holding

Funds holding: 50 → 56 (+6)

1.01% more ownership

Funds ownership: 10.4% → 11.42% (+1%)

Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
19
Reduced
8
Closed
5
Calls
$3.44M
Puts
$2.23M
Net Calls
+$1.22M
Net Calls Change
-$611K

Top Buyers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
+$925K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$561K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$261K
4
Simplex Trading
Simplex Trading
Illinois
+$248K
5
Group One Trading
Group One Trading
Illinois
+$173K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$272K
2
Two Sigma Investments
Two Sigma Investments
New York
-$257K
3
CSS
Cubist Systematic Strategies
Connecticut
-$151K
4
VF
Virtu Financial
New York
-$144K
5
Citadel Advisors
Citadel Advisors
Florida
-$76.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$115K +$98K +15,763 New
DU
27
Delphia (USA)
Ontario, Canada
$105K -$21.4K -3,443 -19%
Rockefeller Capital Management
28
Rockefeller Capital Management
New York
$105K +$9.01K +1,450 +11%
CC
29
Corton Capital
Ontario, Canada
$103K -$14.4K -2,319 -14%
VF
30
Virtu Financial
New York
$93K -$144K -23,199 -65%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$90K -$272K -43,828 -78%
LSA
32
Leonteq Securities AG
Switzerland
$89.3K +$24.9K +4,000 +50%
PCM
33
Perritt Capital Management
Illinois
$89K – – –
Goldman Sachs
34
Goldman Sachs
New York
$74K +$62.5K +10,055 New
Citigroup
35
Citigroup
New York
$56K +$47.4K +7,629 New
Wells Fargo
36
Wells Fargo
California
$37K +$50 +8 +0.2%
TRCT
37
Tower Research Capital (TRC)
New York
$33K -$7.71K -1,241 -21%
CG
38
Cutler Group
California
$23K +$1.98K +319 +11%
Osaic Holdings
39
Osaic Holdings
Arizona
$21K – – –
UBS Group
40
UBS Group
Switzerland
$13K +$11.2K +1,800 +5,000%
Carson Wealth (CWM LLC)
41
Carson Wealth (CWM LLC)
Nebraska
$12K – – –
EL
42
EMFO LLC
Florida
$12K – – –
FDCDDQ
43
Federation des caisses Desjardins du Quebec
Quebec, Canada
$9.59K – – –
National Bank of Canada
44
National Bank of Canada
Quebec, Canada
$6K – – –
HFM
45
Hartford Financial Management
Connecticut
$4K – – –
GFPC
46
Global Financial Private Client
Florida
$1.97K – – –
RG
47
Retirement Group
California
$1K -$6.53K -1,050 -93%
Northwestern Mutual Wealth Management
48
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
TWA
49
TCI Wealth Advisors
Arizona
$1K – – –
HBW
50
Hazlett, Burt & Watson
West Virginia
$1K +$1.24K +200 New
1
2
3

ATNM Hedge Fund Activity: Q3 2022 in Review

56 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q3 2022, worth a combined $21.2M — up 78% from $11.9M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ATNM positions and 5 closed out — a net gain of 6 holders — while 19 added to existing stakes and 8 trimmed.

The largest buyer was J. Goldman & Co, opening a new position worth an estimated $925K. The largest seller was Susquehanna International Group, cutting an estimated $272K.

  • 56 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q3 2022, up from 50 in Q2 2022.
  • Funds reported $21.2M of Actinium Pharmaceuticals stock for Q3 2022, up 78% quarter-over-quarter.
  • 11 funds opened new Actinium Pharmaceuticals positions in Q3 2022 and 5 closed out, a net change of +6 holders.
  • The largest Actinium Pharmaceuticals buyer in Q3 2022 was J. Goldman & Co, an estimated $925K added.
  • The largest Actinium Pharmaceuticals seller in Q3 2022 was Susquehanna International Group, an estimated $272K sold.

Based on aggregated 13F filings for Q3 2022.